Nexizol (Esomeprazole)

Esomeprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme (gastric proton pump) in the parietal cells of the stomach. By blocking this final step of acid secretion, it raises gastric pH, reduces both basal and stimulated acid output, and creates an environment conducive to mucosal healing.

The appropriate dose of Nexizol is determined by the prescribing clinician based on the specific indication, patient characteristics, and local treatment guidelines. Dosage forms and strengths are selected to achieve the desired therapeutic effect while minimizing risk, and patients should follow the prescriber’s instructions exactly.

Safety data for esomeprazole in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified health professional after a careful risk‑benefit assessment.

To place an order, submit an enquiry on the Nexizol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nexizol (esomeprazole) is the S‑enantiomer of omeprazole and generally provides more consistent acid suppression with a slightly improved pharmacokinetic profile. Compared with other PPIs such as lansoprazole or pantoprazole, it may achieve faster onset of action and higher intragastric pH, though clinical outcomes are similar and choice often depends on individual response and tolerability.

Nexizol should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid environments such as bathrooms. Do not use if the packaging is damaged or the tablets appear discolored.

Nexizol is taken orally, usually with a glass of water. It may be administered with or without food, although taking it before a meal can enhance its acid‑suppression effect. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed by a healthcare professional.

Although rare, serious adverse events can include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, hypomagnesemia leading to muscle cramps or cardiac arrhythmias, and increased risk of bone fractures with long‑term use. Patients experiencing any of these symptoms should seek immediate medical attention.

Nexizol is contraindicated in individuals with known hypersensitivity to esomeprazole or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, those taking medications that require an acidic environment for absorption, and patients with a history of low magnesium levels or osteoporosis unless closely monitored.